Cell and gene therapy are rapidly evolving disciplines of precision medicine that have shown promise in treating various diseases or medical needs in humans. Despite both existing in the field of precision medicine they are functionally different techniques. Current examples of cell and gene therapy are:
Cell therapy aims to repair or replace damaged cells via the implantation of healthy cells into the body. Cell therapy has existed for some time in forms such as blood or marrow transfusions, however, recent advancements in the field have provided promising additional treatments utilizing cell therapy. In contrast, gene therapy relies on the modification or manipulation of a gene expression or biological process to achieve a therapeutic outcome.[2] Gene therapy can work in several ways including:
In the United States, The Center for Biologics Evaluation and Research (CBER) utilizes the Public Health Service Act and the Federal Food Drug and Cosmetic Act to regulate cell and gene products as well as devices related to cell and gene therapy.[5] Currently, CBER has approved over 30 cell and gene therapy products.[6] In the United Kingdom, cell and gene therapies (also called advanced therapy medicinal products, or ATMP) are regulated by The Medicines and Healthcare Products Regulatory Agency (MHRA). MHRA is the governing body responsible for both the clinical trial authorization as well as overseeing the importation or manufacture of ATMP.[7]
Cell and gene therapy is a diverse field requiring an equally diverse array of laboratory instrumentation. Instruments that are currently used throughout cell and gene therapy research and development include:
Keep up with the latest laboratory equipment. Plus, get special offers and more delivered to your inbox.